Skip to main content
Nanochon secured $4.1M in funding to launch first-in-human trials for its 3D-printed knee implant.
Funding
1 min read

Nanochon secured $4.1M in funding to launch first-in-human trials for its 3D-printed knee implant.

Nanochon
Nanochon

Application

Originally reported by The Business Journals

Nanochon secured $4.1M in funding to launch first-in-human trials for its 3D-printed knee implant. The Chondrograft technology uses a regenerative scaffold to regrow tissue, moving orthopedics beyond permanent metal parts. This Phase I study with 10 patients marks a systemic shift toward bio-integrative additive manufacturing. This solution could eliminate the need for total knee replacements in younger patients. 🚀🦴 #AdditiveManufacturing #3DPrinting #MedTech #Nanochon

Explore NanochonRead Original

How This Connects

6 related events
  1. Same pattern

    CollPlant has launched BioFlex, a ready-to-print rhCollagen kit optimized for high-resolution Digital Light Processing (DLP) 3D bioprinting.

  2. Same pattern

    Auxilium Biotechnologies is partnering with Starlab Space to deploy the AMP-1 bioprinting platform for scalable medical manufacturing in low Earth orbit.

  3. Same pattern

    PrintBio has joined a federal consortium led by WFIRM to receive up to 24.8 million USD from ARPA-H for bioprinting vascularized kidney tissue.

  4. Same pattern

    Pandorum Technologies secured 18 million dollars in Series B funding to advance its 3D bioprinting and regenerative medicine pipeline.

  5. Same pattern

    Carnegie Mellon University secured a 28.5 million dollar ARPA-H award for the LIVE project, developing 3D-printed human liver patches.

  6. Same pattern

    Aspect Biosystems has expanded its partnership with Novo Nordisk to develop bioprinted islet therapies for Type 1 diabetes.

  7. This article

    Nanochon secured $4.1M in funding to launch first-in-human trials for its 3D-printed knee implant.